Other News

Nihon Kohden Launches Aireeg® WEE-1200 Wireless EEG System at HIMSS18

IRVINE, Calif.–(BUSINESS WIRE)– Nihon Kohden Corporation, a U.S. market leader in precision medical products and services, has launched its aireeg®WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments. The smart, safe and secure […]

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S.

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the OrbusNeich® 1.0mm Sapphire® II PRO coronary balloon. OrbusNeich’s […]

Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures

MENLO PARK, Calif. & ORLANDO, Fla.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced positive safety and effectiveness data from a physician-sponsored U.S. study of the company’s Tempo® Temporary Pacing Lead. Results from a multi-center retrospective analysis of 224 U.S. interventional cardiac procedures, including transcatheter aortic valve […]

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that findings from the “Vest Prevention of Early Sudden Death Trial” (VEST Trial) on use of the ZOLL LifeVest® wearable cardioverter defibrillator (WCD) will be presented as a Late-Breaking Clinical Trial at the American […]

4C Medical’s Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting

BROOKLYN PARK, Minn., March 1, 2018 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, today announced that its medical device for mitral regurgitation (MR) will be highlighted in two presentations at the Cardiovascular Research Technologies (CRT) meeting held March 3-6, 2018 in Washington, DC.  4C Medical […]

New Biocompatible Embolic Device to Control Blood Flow & Treat Tumors Presented at the Leipzig Interventional Congress (LINC)

GPX is a biocompatible gel-particle embolic device that transforms from low-viscosity particles in a syringe to a solid particle after injection into a vessel LEIPZIG, GERMANY, February 01, 2018 /24-7PressRelease/ — Two scientific abstracts of a new vascular embolic device were presented this week at the 2018 Leipzig Interventional Congress […]

Scandinavian Real Heart Selects AdaCore Embedded Software Development Platform for Revolutionary Artificial Heart

NEW YORK & PARIS & NUREMBERG, Germany–(BUSINESS WIRE)–Embedded World–AdaCore, a trusted provider of software development and verification tools with headquarters in New York and Paris, today announced that Scandinavian Real Heart AB in Sweden is using a suite of AdaCore software solutions to develop reliable embedded software for its revolutionary Total Artificial […]

Global Embolic Protection Devices Market 2018-2023 by Type, Material, Application, Indication – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Embolic Protection Devices Market is Projected to Reach USD 604.9 Million By 2023 from USD […]